% Expired Patents = 100.0

Forward Citations = 56

Loading Chart...

7 inventors (with patents filed for the assignee):

Juswinder Singh (5 out of 68 patents)

Russell Colyn Petter (5 out of 82 patents)

Arthur F Kluge (4 out of 96 patents)

4. Shomir Ghosh (3 out of 71 patents)

5. Richland Wayne Tester (2 out of 30 patents)

6. Deqiang Niu (2 out of 83 patents)

7. Lixin Qiao (2 out of 40 patents)

5 patents: Sort by Forward Citations

1. 8293705 - HCV protease inhibitors and uses thereof (2012-10-23),

2. 8242271 - Heterocyclic compounds and uses thereof (2012-08-14),

3. 8188137 - HCV protease inhibitors and uses thereof (2012-05-29),

4. 7989465 - 4,6-disubstituted pyrimidines useful as kinase inhibitors (2011-08-02),

5. 7982036 - 4,6-disubstitued pyrimidines useful as kinase inhibitors (2011-07-19),

Company Overview

Avila Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for cancer and autoimmune diseases. Their proprietary technology platform allows for the rapid discovery and optimization of small molecule drugs targeting specific proteins involved in disease pathways. With a pipeline of promising drug candidates in preclinical and clinical development, Avila Therapeutics is dedicated to transforming the way these devastating diseases are treated.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#75 in Bedford, MA

#2,894 in Massachusetts

#51,620 in US

Bedford, MA, United States of America

Avila Therapeutics, Inc.

Forward Citations = 56

7 inventors:

Juswinder Singh (5 out of 68 patents)

Russell Colyn Petter (5 out of 82 patents)

Arthur F Kluge (4 out of 96 patents)

4. Shomir Ghosh (3 out of 71 patents)

5. Richland Wayne Tester (2 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Avila Therapeutics, Inc.. Retrieved from https://idiyas.com/company/avila-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]